News

Life Science Leader — Leading Through Adversity: A CEO Roundtable on Drug Development During a Pandemic

lifescileader

Four biopharma CEOs discuss with Rob Wright, chief editor of Life Science Leader, how they are leading their organizations and conducting drug development during the COVID-19 pandemic. Appearing in this video are: Jeremy Levin, DPhil, MB, BChir, CEO of Ovid TherapeuticsGil Van Bokkelen, Ph.D., chairman and CEO of AthersysRachel King, CEO, GlycoMimeticsTed Love, M.D., President […]

Comments Off on Life Science Leader — Leading Through Adversity: A CEO Roundtable on Drug Development During a Pandemic Continue Reading →

BBJ: UMB startup company’s exclusive licensed tool supports health care professionals

pumasjpg

By Jamie Lacey-Moreira – For the University of Maryland, Baltimore (UMB)A company spun out of the University of Maryland School of Pharmacy aims to leverage its approach — combining modern artificial intelligence (AI) with traditional mechanistic models — to arm health care professionals with the best data to provide personalized treatment trajectories for patients. Pumas-Al, […]

Comments Off on BBJ: UMB startup company’s exclusive licensed tool supports health care professionals Continue Reading →

APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401

MAXCYTE-New-Logo-2016-LARGE

APEIRON to utilize MaxCyte’s ExPERT® platform for siRNA-based cell therapy APN401 targeting solid tumors and secures manufacturing for upcoming clinical trials VIENNA, AUSTRIA and GAITHERSBURG, MD, July 8, 2020 APEIRON Biologics AG (“APEIRON”), a private biotechnology company specializing in the discovery, development and commercialization of novel immunotherapies for cancer and respiratory diseases, and MaxCyte, Inc., a […]

Comments Off on APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401 Continue Reading →

Protaryx Medical Announces $8.3M in Funding for First-in-Class Technology for Left Atrial Access in Transcatheter Cardiac Procedures

Protaryx

$5.1M Series A Funding Led by Ajax Health Will Be Used to Develop First-in-Class Product Designed with Three-Dimensional, Independent Steerability to Deliver Reliable Access BALTIMORE–(BUSINESS WIRE)–Protaryx™ Medical, a company committed to reimagining access to the left atrium for transcatheter cardiac procedures, today announced that it has raised $8.3 million in funding to develop the company’s […]

Comments Off on Protaryx Medical Announces $8.3M in Funding for First-in-Class Technology for Left Atrial Access in Transcatheter Cardiac Procedures Continue Reading →

BioBuzz: Former MedImmune Employees Leading In the BioHealth Capital Region and Beyond

BioBuzzLogo

In a recent conversation someone shared the quote “You can’t throw a stone in the BioHealth Capital Region and not hit somebody who worked at MedImmune”. This statement emphasizes how important the company was in seeding the growth of the biotech industry in Maryland. Founded by Wayne T. Hockmeyer in 1988 as Molecular Vaccines, Inc., […]

Comments Off on BioBuzz: Former MedImmune Employees Leading In the BioHealth Capital Region and Beyond Continue Reading →

UMB Startup Breethe Acquired by Abiomed to Commercialize Wearable Artificial Lung System

BreetheNew

The Deal Marks Another Successful Exit Supported by UM Ventures Breethe, a company built on technology licensed out of the University of Maryland, Baltimore (UMB), was acquired by Abiomed, a publicly-traded medical device company located in Massachusetts, in late April 2020. Financials were not disclosed, but the deal represents another UMB success story that received early backing […]

Comments Off on UMB Startup Breethe Acquired by Abiomed to Commercialize Wearable Artificial Lung System Continue Reading →

MaxCyte to Share Preliminary Phase I Data on MCY-M11 at ASCO 2020 Annual Meeting

Maxcyte logo square

Gaithersburg, Maryland – May 18, 2020: – MaxCyte, the global clinical-stage cell-based therapies and life sciences company, announces that clinical data from the first three cohorts of the ongoing Phase I dose-escalation trial demonstrating safety of MCY-M11 and feasibility of one-day manufacturing will be shared at the American Society of Clinical Oncology’s (ASCO) upcoming annual meeting. […]

Comments Off on MaxCyte to Share Preliminary Phase I Data on MCY-M11 at ASCO 2020 Annual Meeting Continue Reading →

CapitalM ZoomCast Live – COVID Series — A Discussion with Jim Hughes: Advancing UMB-Born Technologies in the Fight Against COVID-19 & Beyond

CapitalM2

Marty Rosendale’s guest, Jim Hughes, Senior Vice President and Chief Enterprise & Economic Development Officer at University of Maryland, Baltimore shared how university physicians, faculty/researchers and tech transfer professionals are working to bring innovations to life to help clinicians on the front line treat patients and fight COVID-19.  Watch here » | Listen here » 

Comments Off on CapitalM ZoomCast Live – COVID Series — A Discussion with Jim Hughes: Advancing UMB-Born Technologies in the Fight Against COVID-19 & Beyond Continue Reading →

UMB Grants Pumas-AI Exclusive License for Lyv, a Cutting-Edge Clinical Decision Support System

pumasjpg

Company spun out of University of Maryland School of Pharmacy aims to leverage its approach — combining modern artificial intelligence (AI) with traditional mechanistic models — to arm health care professionals with the best data to provide personalized treatment trajectories for patients BALTIMORE, May 7, 2020 /PRNewswire/ — Pumas-AI, a University of Maryland, Baltimore (UMB) startup company, has been granted worldwide, exclusive rights […]

Comments Off on UMB Grants Pumas-AI Exclusive License for Lyv, a Cutting-Edge Clinical Decision Support System Continue Reading →

Technical.ly Baltimore: UMB-born medical device company Breethe acquired by Abiomed

BreetheNew

The Halethorpe-based company’s lung-like technology will become part of the product portfolio of Massachusetts’ Abiomed. Breethe, the medical device company founded by renowned University of Maryland School of Medicine surgeon and professor Dr. Bartley Griffith, has been acquired by Danvers, Massachusetts-based Abiomed, the companies announced this week. Breethe’s system, which is designed to behave like a human lung, will […]

Comments Off on Technical.ly Baltimore: UMB-born medical device company Breethe acquired by Abiomed Continue Reading →